MCMona Clappier

Mona Clappier

*This is an algorithmically generated author record based on publicly available information.

Mona Clappier has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Author Correction: The estrous cycle modulates early-life adversity effects on mouse avoidance behavior through progesterone signaling

    by Blake J. Laham, Sahana S. Murthy, Monica Hanani, Mona Clappier, Sydney Boyer, Betsy Vasquez, Elizabeth Gould

  • Open Access

    The estrous cycle modulates early-life adversity effects on mouse avoidance behavior through progesterone signaling

    by Blake J. Laham, Sahana S. Murthy, Monica Hanani, Mona Clappier, Sydney Boyer, Betsy Vasquez, Elizabeth Gould

    Early-life adversity (ELA) increases the likelihood of neuropsychiatric diagnoses, which are more prevalent in women than men. Since changes in reproductive hormone levels can also increase the probability of anxiety disorders in women, we examined the effects of ELA on adult female mice across the estrous cycle. We found that during diestrus, when progesterone levels are relatively high, ELA mice exhibit increased avoidance behavior and increased theta oscillation power in the ventral hippocampus (vHIP). We also found that diestrus ELA mice had higher levels of progesterone and lower levels of allopregnanolone, a neurosteroid metabolite of progesterone, in the vHIP compared with control-reared mice. Progesterone receptor antagonism normalized avoidance behavior in ELA mice, while treatment with a negative allosteric modulator of allopregnanolone promoted avoidance behavior in control mice. These results suggest that altered vHIP progesterone and allopregnanolone signaling during diestrus increases avoidance behavior in ELA mice.


  • Discussion: A Guide to Industry Payments and an Algorithm for Their Management

    by Neil M.D. Tanna, Mona B.A. Clappier, Armen K. Kasabian

  • Conflict of Interest at Microsurgery Conferences: Disclosure of Its Extent and Nature

    by Grace Ha, Rachel Gray, Mona Clappier, Neil Tanna, Armen K. Kasabian

    Background Industry relationships and conflicts of interest can impact research funding, topics, and outcomes. Little research regarding the role of biomedical companies at microsurgery conferences is available. This study evaluates the role of industry at conferences by comparing payments received by speakers at the American Society for Reconstructive Microsurgeons (ASRM) meeting with those received by speakers at the American Society of Aesthetic Plastic Surgeons (ASAPS) meeting, the American Society of Plastic Surgeons (ASPS) meeting, and an average plastic surgeon. It also compares payments made by different companies. Methods General payments received by speakers at the 2017 ASAPS, ASPS, and ASRM conferences were collected from the Open Payments Database. Mean payments received at each conference were calculated and the Mann–Whitney U test evaluated differences between conference speakers and the average plastic surgeon. The total amount of payments from each company was collected through the Open Payments Database, and Z-tests identified which companies paid significantly more than others. Results The mean (and median) general payments made to conference speakers at ASAPS (n = 75), ASPS (n = 247), and ASRM (n = 121) were $75,577 ($861), $27,562 ($1,021), and $16,725 ($652), respectively. These payments were significantly greater (p < 0.001 for all) than those of the average plastic surgeon ($4,441 and $327), but not significantly different from each other. Allergan contributed significantly more than other companies to speakers at ASPS and ASAPS, while LifeCell Corporation, Zimmer Biomet Holdings, and Axogen contributed significantly more to speakers at ASRM. Conclusion Payments to physicians at ASRM were significantly higher than those of an average plastic surgeon but not significantly different from those of speakers at ASAPS and ASPS. Certain companies paid significantly more than their peers at each conference. Given these findings, speakers should strive to make clear the nature and extent of their conflicts of interest when presenting at conferences.


  • Complications of operative vaginal delivery and provider volume and experience

    by Kelly Yamasato, Chieko Kimata, Ingrid Chern, Mona Clappier, Janet Burlingame

    Objective: To evaluate associations between operative vaginal delivery complications and provider experience (operative vaginal delivery volume and time since residency). Methods: We included all operative vaginal deliveries between 2008 and 2014 at a tertiary care teaching hospital, stratified into forceps-assisted and vacuum-assisted deliveries. Complications included severe perineal lacerations (3rd and 4th degree) and neonatal injuries (subgaleal/subdural/cerebral hemorrhage, facial nerve injury, and scalp injury), which were identified by International Classification Diagnosis-9 codes. Providers were categorized by operative vaginal delivery volume (mean annual forceps- or vacuum-assisted deliveries over the study interval) and time since residency. Regression analyses were used to compare complication rates by provider volume and time since residency, adjusting for potential confounders, using 0–1 deliveries per year and 10 forceps per year (aOR 0.50 [95%CI 0.30–0.81]) and at 15–19 years (aOR 0.45 [95% CI 0.22–0.94], and ≥25 years (aOR 0.45 [0.27–0.73]) since residency. There were no associations with neonatal injuries. Among vacuum-assisted deliveries, severe perineal injury decreased at ≥25 years since residency (aOR 0.35 [95%CI 0.17–0.74], with no association with provider volume. Neonatal injury decreased at 5–9 years (aOR 0.53 [95%CI 0.30–0.93]), and 15–19 years since residency (aOR 0.53 [95%CI 0.29–0.97]), due to differences in scalp injuries. Neonatal injuries other than scalp injury were rare. Conclusion: Severe perineal lacerations decreased with increasing operative vaginal delivery experience, primarily among forceps-assisted vaginal delivery. Providers >5 years since residency may have lower scalp injury with vacuums, but this cohort was largely underpowered for neonatal injury.